Cahaba Research, Inc   Report issue

For profit Phase 2
Founded: Birmingham AL United States (2002)

Organization Overview

First Clinical Trial
2007
NCT00409305
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2012

Timeline

NOW
  • Now

Alternative names

Cahaba Research, Birmingham, AL 35242

Active Ingredients

Drugs in Phase 2 Trials (2)

betahistine mesilate (1 trial)

favipiravir (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Body Weight (Phase 2)

Influenza, Human (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 2
  • # of Trial APIs: 2